Concepedia

Pijus K. Mandal

PK

Statistics

Publications

33

Citations

1.8K

H-Index

24

Active since

1995

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Indian Association for the Cultivation of Science

University of Houston

Baylor College of Medicine

Michael E. DeBakey VA Medical Center

Pijus K. Mandal is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, signal transduction, and medicinal chemistry.

Publications per year

1995–2021

33

Publications

33

Pd−C-Induced Catalytic Transfer Hydrogenation with Triethylsilane

Pijus K. Mandal, John S. McMurray · The Journal of Organic Chemistry · 2007 · 203 citations

, , +16

Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer

Omar Rahal, Adam R. Wolfe, Pijus K. Mandal et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 166 citations · Full text

, , +17

Investigation of the Binding Determinants of Phosphopeptides Targeted to the Src Homology 2 Domain of the Signal Transducer and Activator of Transcription 3. Development of a High-Affinity Peptide Inhibitor

Zhiyong Ren, Pijus K. Mandal, Arlin G. Cameron et al. · Journal of Medicinal Chemistry · 2005 · 126 citations · Full text

, , +17

Potent and Selective Phosphopeptide Mimetic Prodrugs Targeted to the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 3

Pijus K. Mandal, Fengqin Gao, Zhen Lü et al. · Journal of Medicinal Chemistry · 2011 · 124 citations · Full text

, , +17

Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib

Yuting Sun, Brooke A. Meyers, Barbara Czakó et al. · Cancer Research · 2020 · 106 citations · Full text

, , +17

1–5 of 33